Trial · NCT07199504
A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole
NCT07199504, Phase 2, Phase 3, Recruiting, Yunfeng Xia
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole. Trials, record NCT07199504. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07199504
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole
- NCT number
- NCT07199504
- Status
- Recruiting
- Phases
- Phase 2, Phase 3
- Enrollment
- 80 participants, estimated
- Lead sponsor
- Yunfeng Xia
- Conditions
- Restless Leg Syndrome Due to Uraemia
- Interventions
- Dipyridamole 50mg tid
- First posted
- 2025-09-30
- Last updated
- 2026-04-22
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | International Restless Legs Syndrome Study Group rating scale | From enrollment to the end of treatment at 12 weeks | The treatment effect on participants' restless legs syndrome is mainly assessed through their scores on the International Restless Legs Syndrome Study Group rating scale before and after treatment. |
| Secondary | Hamilton Depression Rating Scale | From enrollment to the end of treatment at 12 weeks | The changes in participants' depressive symptoms were assessed using the Hamilton Depression Rating Scale before and after they received treatment. |
| Secondary | Hamilton Anxiety Scale | From enrollment to the end of treatment at 12 weeks | The changes in participants' anxiety levels were assessed using the Hamilton Anxiety Scale before and after they received treatment. |
| Secondary | Pittsburgh Sleep Quality Index | From enrollment to the end of treatment at 12 weeks | The changes in participants' sleep quality were assessed using the Pittsburgh Sleep Quality Index before and after they received treatment. |
| Secondary | KDQOL-36 Scale | From enrollment to the end of treatment at 12 weeks | Changes in participants' quality of life were assessed using the KDQOL-36 Scale before and after they received treatment. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07199504
GET https://conductscience.org/api/trials/v1/NCT07199504/registered